The cybersecurity risk is the latest in a series of issues that the pumps, and Medtronic’s diabetes business, have faced in recent months.
Medtronic began alerting patients Tuesday of a technological weakness in its MiniMed 600 Series insulin pumps that makes it vulnerable to hacking, the latest in a series of problems for the device and the company’s diabetes business.
Medtronic said it is not possible for someone to gain unauthorized pump access through the internet.
In an earnings call last month, Medtronic chief executive Geoff Martha said the company has “completed more than 90% of the actions we committed to the FDA” in response to the warning letter.
